BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 6523177)

  • 1. Cardiac abnormalities in the thalassaemia syndromes.
    Yee H; Mra R; Nyunt KM
    Southeast Asian J Trop Med Public Health; 1984 Sep; 15(3):414-21. PubMed ID: 6523177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of early cardiac dysfunction in patients with severe beta-thalassemia and chronic iron overload.
    Leon MB; Borer JS; Bacharach SL; Green MV; Benz EJ; Griffith P; Nienhuis AW
    N Engl J Med; 1979 Nov; 301(21):1143-8. PubMed ID: 492276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hemosiderosis in thalassemia major. Quantitative study with magnetic resonance (MR)].
    Rossi L; Castriota-Scanderbeg A; Ferrozzi F; Butturini A; Rossi A
    Radiol Med; 1992 Mar; 83(3):237-42. PubMed ID: 1579672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac study by dobutamine stress echocardiography in thalassemic patients.
    Mariotti E; Agostini A; Angelucci E; Cesaroni P; Lucarelli G; Sgarbi E
    Bone Marrow Transplant; 1993; 12 Suppl 1():14-5. PubMed ID: 8374553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chelation therapy in beta-thalassemia: the benefits and limitations of desferrioxamine.
    Giardina PJ; Grady RW
    Semin Hematol; 1995 Oct; 32(4):304-12. PubMed ID: 8560288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocrine complications in transfusion dependent thalassaemia in Penang Hospital.
    Ong CK; Lim SL; Tan WC; Ong EE; Goh AS
    Med J Malaysia; 2008 Jun; 63(2):109-12. PubMed ID: 18942294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac complications in homozygous beta-thalassemia.
    Wonke B; Hoffbrand AV; Aldouri MA; Ward SE
    Prog Clin Biol Res; 1989; 309():51-6. PubMed ID: 2780750
    [No Abstract]   [Full Text] [Related]  

  • 8. Detection of the cardiovascular complications of thalassemia by echocardiography.
    Walker JM; Nair S
    Ann N Y Acad Sci; 2010 Aug; 1202():165-72. PubMed ID: 20712789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac pathology in 47 patients with beta thalassaemia/haemoglobin E.
    Sonakul D; Pacharee P; Wasi P; Fucharoen S
    Southeast Asian J Trop Med Public Health; 1984 Dec; 15(4):554-63. PubMed ID: 6242076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cardiac dysfunction in children with thalassemia major].
    Angelika L; Graf N; Hoffmann W
    Klin Padiatr; 1988; 200(2):102-7. PubMed ID: 3386182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cardiac manifestations of thalassemia major: natural history, noninvasive cardiac diagnostic studies and results of cardiac catheterization.
    Ehlers KH; Levin AR; Klein AA; Markenson AL; O'Loughlin JE; Engle MA
    Cardiovasc Clin; 1981; 11(2):171-86. PubMed ID: 7214380
    [No Abstract]   [Full Text] [Related]  

  • 12. MRI and iron-overload cardiomyopathy in thalassaemia.
    Pennell D
    Circulation; 2006 Mar; 113(11):f43-4. PubMed ID: 16552847
    [No Abstract]   [Full Text] [Related]  

  • 13. The heart in thalassemia: a comprehensive review.
    Sahasakul Y; Chithiraphan S
    J Med Assoc Thai; 1985 Oct; 68(10):517-27. PubMed ID: 3908610
    [No Abstract]   [Full Text] [Related]  

  • 14. Echocardiographic study in ex-thalassemic patients with iron overload, preliminary observations during phlebotomy therapy.
    Mariotti E; Agostini A; Angelucci E; Lucarelli G; Sgarbi E
    Bone Marrow Transplant; 1993; 12 Suppl 1():106-7. PubMed ID: 8374547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Echocardiographic abnormalities in thalassaemia major with multiple transfusions.
    Ee B; Tan SH; Yip WC; Tay JS; Chia BL; Wong HB
    J Singapore Paediatr Soc; 1981; 23(1-2):68-70. PubMed ID: 7343780
    [No Abstract]   [Full Text] [Related]  

  • 16. Increased prevalence of iron-overload associated endocrinopathy in thalassaemia versus sickle-cell disease.
    Fung EB; Harmatz PR; Lee PD; Milet M; Bellevue R; Jeng MR; Kalinyak KA; Hudes M; Bhatia S; Vichinsky EP;
    Br J Haematol; 2006 Nov; 135(4):574-82. PubMed ID: 17054676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life in transfusion-dependent thalassaemia patients on desferrioxamine treatment.
    Dahlui M; Hishamshah MI; Rahman AJ; Aljunid SM
    Singapore Med J; 2009 Aug; 50(8):794-9. PubMed ID: 19710979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High nontransferrin bound iron levels and heart disease in thalassemia major.
    Piga A; Longo F; Duca L; Roggero S; Vinciguerra T; Calabrese R; Hershko C; Cappellini MD
    Am J Hematol; 2009 Jan; 84(1):29-33. PubMed ID: 19006228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of cardiac function in patients with thalassemia major.
    Nienhuis AW; Griffith P; Strawczynski H; Henry W; Borer J; Leon M; Anderson WF
    Ann N Y Acad Sci; 1980; 344():384-96. PubMed ID: 6930878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron overload in thalassemia: comparative analysis of magnetic resonance imaging, serum ferritin and iron content of the liver.
    Mazza P; Giua R; De Marco S; Bonetti MG; Amurri B; Masi C; Lazzari G; Rizzo C; Cervellera M; Peluso A
    Haematologica; 1995; 80(5):398-404. PubMed ID: 8566878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.